High expression of the mCRPs membrane cofactor protein (CD46), decay-accelerating factor (CD55), and CD59 (protectin) on tumor cells is associated with increased metastatic potential, and poor prognosis in a range of tumors (31–34). Here, CD46 is linked to neoplasm.